MM

Manorama Mohapatra

Active Director Director DIN 09800200
DIN 09800200 First appointment Nov 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Manorama Mohapatra

Data last updated:

Manorama Mohapatra is a Director at Pharma Marts Private Limited (since 2022). The company operates in Trading. Pharma Marts Private Limited reported revenue of ₹5.7 Lakh (FY 2024).

DIN 09800200
Primary Designation Director
Industry Trading
First Appointment 14 Nov 2022
Oldest Company Age 6 yrs
Largest company Pharma Marts Private Limited · ₹5.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharma Marts Private Limited U51909OR2020PTC033865
Director14 Nov 20222020₹5.7 Lakh (FY 2024)Active

Board colleagues of Manorama Mohapatra

Directorship timeline

Open interactive timeline →
Pharma Marts Private Limited
Premium access

Shareholding and investment profile for Manorama Mohapatra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manorama Mohapatra

Manorama Mohapatra currently holds 1 directorship: Pharma Marts Private Limited (Director, since 14 Nov 2022, revenue ₹5.7 Lakh (FY 2024)).

Manorama Mohapatra was first appointed on 14 Nov 2022 as Director at Pharma Marts Private Limited.

The current boards of Manorama Mohapatra's companies include Jagdish Singh (Pharma Marts Private Limited), Prasanta Kumar Mohapatra (Pharma Marts Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available